- Home
- LEE vs ICCM Comparison
LEE vs ICCM Comparison
Compare LEE & ICCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LEE
- ICCM
- Stock Information
- Founded
- LEE 1890
- ICCM 2006
- Country
- LEE United States
- ICCM Israel
- Employees
- LEE N/A
- ICCM N/A
- Industry
- LEE Newspapers/Magazines
- ICCM
- Sector
- LEE Consumer Discretionary
- ICCM
- Exchange
- LEE Nasdaq
- ICCM Nasdaq
- Market Cap
- LEE 52.4M
- ICCM 59.5M
- IPO Year
- LEE N/A
- ICCM N/A
- Fundamental
- Price
- LEE $6.30
- ICCM $0.95
- Analyst Decision
- LEE
- ICCM Strong Buy
- Analyst Count
- LEE 0
- ICCM 1
- Target Price
- LEE N/A
- ICCM $2.50
- AVG Volume (30 Days)
- LEE 18.0K
- ICCM 221.0K
- Earning Date
- LEE 07-31-2025
- ICCM 08-19-2025
- Dividend Yield
- LEE N/A
- ICCM N/A
- EPS Growth
- LEE N/A
- ICCM N/A
- EPS
- LEE N/A
- ICCM N/A
- Revenue
- LEE $591,094,000.00
- ICCM $3,273,000.00
- Revenue This Year
- LEE N/A
- ICCM $83.41
- Revenue Next Year
- LEE N/A
- ICCM $185.02
- P/E Ratio
- LEE N/A
- ICCM N/A
- Revenue Growth
- LEE N/A
- ICCM 0.34
- 52 Week Low
- LEE $6.00
- ICCM $0.48
- 52 Week High
- LEE $19.63
- ICCM $1.66
- Technical
- Relative Strength Index (RSI)
- LEE 32.43
- ICCM 37.48
- Support Level
- LEE $6.20
- ICCM $0.98
- Resistance Level
- LEE $6.72
- ICCM $1.00
- Average True Range (ATR)
- LEE 0.39
- ICCM 0.04
- MACD
- LEE 0.03
- ICCM -0.00
- Stochastic Oscillator
- LEE 21.00
- ICCM 6.46
About LEE Lee Enterprises Incorporated
Lee Enterprises Inc is a local news publication company in the United States. It is a digital-first subscription business providing local markets with valuable, high-quality, trusted, intensely local news, information, advertising, and marketing services. The product portfolio of the company includes digital subscription platforms, daily, weekly, and monthly newspapers, and niche products, all delivering original local news and information as well as national and international news. The products offer digital and print editions, and content and advertising are available in real-time through the websites and mobile apps.
About ICCM IceCure Medical Ltd.
Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.